Sign In
Buy IMMU
$87.86
+0 (+0%)
At Close: May 27, 2022
Biotech's Golden Moment As Healthcare Attracts Investors
01:31pm, Tuesday, 12'th May 2020
Biotechs are not as broadly and deeply affected by COVID-19 disruption and now lead the market as the economy begins the recovery process. Healthcare has attrac
Why Immunomedics Stock Skyrocketed 125% in April
12:19pm, Tuesday, 12'th May 2020
Shares of biotech Immunomedics (NASDAQ: IMMU) skyrocketed 125% in April, according to data from S&P; Global Market Intelligence. The FDA declined to approve the company's TNBC drug in January 2019 b
Industry Analysts Just Upgraded Their Immunomedics, Inc. (NASDAQ:IMMU) Revenue Forecasts By 16%
12:13pm, Tuesday, 12'th May 2020
Immunomedics, Inc. (NASDAQ:IMMU) shareholders will have a reason to smile today, with the analysts making substantial...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 11)
Acceleron Pharma Inc (NASDAQ...
The JESD204B serial interface has become the interface standard of choice for high-speed analog-to-digital and digital-to-analog converters (ADCs and DACs). Intel® FPGAs and Intel® SOC FPGAs are wel
ADC Therapeutics Cuts Price In Second IPO Attempt
04:29pm, Monday, 11'th May 2020
ADC Therapeutics has filed revised terms for a $125 million U.S. IPO. The firm is developing drug treatment candidates for blood cancers and solid tumors. With
Spectrum Pharma (SPPI) Incurs Wider-Than-Expected Q1 Loss
02:41pm, Monday, 11'th May 2020
Spectrum Pharma (SPPI) misses bottom-line estimates for the first quarter and records no revenues.
ENHERTU® Granted Breakthrough Therapy Designation in the U.S. for HER2 Positive Metastatic Gastric Cancer
12:00am, Monday, 11'th May 2020
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been granted Breakthrough
Mantle Cell Lymphoma Treatment Market - Global Industry to Discern Magnified Growth During 2020-2027
02:40am, Friday, 08'th May 2020
May 07, 2020 (Global QYResearch via COMTEX) --
This report studies the global Mantle Cell Lymphoma Treatment market status and forecast, categorizes the...
The Daily Biotech Pulse: Ayala IPO, Pluristem Starts Phase 2 Trial Of COVID Treatment, European Nod For Takeda
12:00am, Friday, 08'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 7)
• Acceleron Pharma Inc (...
Edited Transcript of IMMU earnings conference call or presentation 6-May-20 9:00pm GMT
08:12pm, Thursday, 07'th May 2020
Q1 2020 Immunomedics Inc Earnings Call
